Fundraising Fox
/Companies
Sign in

AnTolRx

Boston, US · Founded 2015 · Delaware corporation · 1 known investors

Find your way into AnTolRx

Sign up to find every way you can get introduced to AnTolRx

  • Your email: who you already know at AnTolRx, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AnTolRx team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

AnTolRx develops immunotherapy therapeutics based on research in immune tolerance, targeting immune-mediated disorders. The company is led by scientists and industry veterans with expertise in drug development and biotechnology commercialization.

BiotechHealthtech

Founders & leadership

AnTolRx was founded in 2015 by Francisco J. Quintana.

FJ
Francisco J. QuintanaScientific Founder, Member of Board of Directors
MCMark Carthy
Mark CarthyFounder and CEO, Member of Board of Directors

Board

SJ
Satish JindalBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2016

▶$1MraisedJul 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Satish JindalDirector
  • Francisco QuintanaDirector
  • Mark CarthyExecutive Officer, Director
Offering amount
$4M
Amount sold
$1M
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Mission BioCapital Platinum Program Holdings LLCMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.
TellBioTellBio is a biotechnology company founded by leading cancer researchers and clinicians from Harvard Medical School and Massachusetts General Hospital. The company focuses on oncology research and development, leveraging circulating tumor cell (CTC) technology and biomedical engineering.

Companies working in the same space as AnTolRx.

Frequently asked questions

What does AnTolRx do?
AnTolRx develops immunotherapy therapeutics based on research in immune tolerance, targeting immune-mediated disorders. The company is led by scientists and industry veterans with expertise in drug development and biotechnology commercialization.
Who founded AnTolRx?
AnTolRx was founded by Francisco J. Quintana in 2015.
Who are AnTolRx's investors?
AnTolRx's investors include RiverVest Venture Partners.
How much funding has AnTolRx raised?
AnTolRx has disclosed $1M raised across 1 round.
Where is AnTolRx headquartered?
AnTolRx is headquartered in Boston, US.